iBio Provides Update on Development of Next-Gen COVID-19 Vaccine Candidate
Go back to iBio Provides Update on Development of Next-Gen COVID-19 Vaccine Candidate| IBIO, Inc. (NASDAQ: IBIO) | Delayed: 1.65 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.65 | 52 Week High | $0.80 | |||
| Open | $1.65 | 52 Week Low | $0.34 | |||
| Day High | $1.65 | P/E | N/A | |||
| Day Low | $1.65 | EPS | $-0.08 | |||
| Volume | 25 | |||||
